Wegovy® FlexTouch® 2.4mg (1 Pen)
16 500,00 PHP
Wegovy® 2.4 mg (semaglutide) FlexTouch® is the maintenance dose of the standard semaglutide titration protocol. In the STEP clinical trials, patients receiving 2.4 mg weekly achieved a mean body weight reduction of approximately 15% over 68 weeks. Discontinuation of therapy is associated with weight regain. Each single-use FlexTouch® pen contains four weekly doses (one month of therapy), administered as a subcutaneous injection once every seven days.
What's included with every Wegovy® 2.4mg order:
- Authentic Novo Nordisk® Wegovy® 2.4mg FlexTouch® pen
- Cold-chain delivery or in-clinic dispense (2–8°C verified)
- Physician prescription review before dispense
- Visible batch number and expiry on every pen
- Ongoing physician supervision for long-term weight management
Wegovy® is a prescription-only medication in the Philippines. Purchase requires a valid prescription from a licensed physician — available through our online consultation or at our BGC and Quezon City clinics.
Quantité
Ordonnance requise
Tous les médicaments sur ordonnance disponibles chez Jan Medical Group sont délivrés exclusivement aux patients disposant d'une prescription valide délivrée par un médecin agréé après consultation.
